Skip to main content

Market Overview

Revance Therapeutics's Earnings Outlook

Share:

On Monday, February 22, Revance Therapeutics (NASDAQ:RVNC) will release its latest earnings report. Benzinga's outlook for Revance Therapeutics is included in the following report.

Net Income, Earnings, And Earnings Per Share

Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.

Earnings And Revenue

Revance Therapeutics EPS will likely be near $1.24 while revenue will be around $8.78 million, according to analysts. In the same quarter last year, Revance Therapeutics reported a loss per share of $0.99 on revenue of $89.00 thousand.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Wall Street analysts who study this company will publish analyst estimates of revenue and EPS. The averages of all analyst EPS and revenue estimates are called the "consensus estimates"; these consensus estimates can have a significant effect on a company's performance during an earnings release. When a company posts earnings or revenue above or below a consensus estimate, it has posted an "earnings surprise", which can really move a stock depending on the difference between actual and estimated values.

The analyst consensus estimate would represent a 25.25% decrease in the company's earnings. Revenue would be up 9765.17% from the same quarter last year. The company's reported EPS has stacked up against analyst estimates in the past like this:

Quarter Q3 2020 Q2 2020 Q1 2020 Q4 2020
EPS Estimate -1.03 -1.01 -0.90 -0.98
EPS Actual -1.34 -1.12 -1.15 -0.99
Revenue Estimate 1.78 M 450.00 K 170.00 K 2.29 M
Revenue Actual 3.83 M 299.00 K 58.00 K 89.00 K

Stock Performance

Shares of Revance Therapeutics were trading at $28.19 as of February 18. Over the last 52-week period, shares are up 3.94%. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. Revance Therapeutics is scheduled to hold the call at 16:30:00 ET and can be accessed here.

 

Related Articles (RVNC)

View Comments and Join the Discussion!

Posted-In: BZI-EPEarnings